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Ketorolac as a component of balanced analgesia after thoracotomy
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SUMMARY
Ketorolac 10 mg or 30 mg i.m., 6 hourly or placebo
was given to 75 patients who had undergone
thoracotomy, in a randomized double-blind study.
All subjects were given intercostal nerve blocks
with bupivacaine and had access to i.v. patient-
controlled morphine. I.m. ketorolac improved the
success rate of the analgesic regimen, with fewer
patients withdrawing from the study because of




It is our practice to use intercostal nerve block with
morphine via patient-controlled analgesia (PCA) for
analgesia after thoracotomy. Unfortunately, many
patients find this inadequate and repeat intercostal
nerve block has to be performed, probably because
the intercostal nerve block regresses within 12-24 h
[1]. In this study, we investigated whether the
addition of regular i.m. ketorolac trometamol
(Toradol, Syntex Pharmaceuticals Ltd) to our basic
regimen improved patient comfort. This was per-
formed in a double-blind, placebo-controlled, ran-
domized study after thoracotomy.
METHODS AND RESULTS
Seventy-five patients (18—75 yr) participated in the
study, which was approved by the regional Ethics
Committee. Exclusion criteria were peptic ulcer
disease, asthma, bleeding diathesis and renal or
hepatic impairment. The nature of the study and the
use of PCA were explained and written consent
obtained. The groups did not differ significantly in
age, height, weight or sex (table I). Surgery was
elective pneumonectomy or lobectomy for carcin-
oma, but in 10 patients segmental resection was
performed (placebo group, three; ketorolac 10 mg,
two; ketorolac 30 mg, five). In eight patients removal
of the lesion was not possible and only thoracotomy
was carried out (placebo, one; ketorolac 10 mg, four;
ketorolac 30 mg, three).
After premedication with i.m. papaveretum and
atropine, anaesthesia was induced with thiopentone
and maintained with nitrous oxide and enflurane in
oxygen. Suxamethonium and alcuronium were used
for neuromuscular block. Intercostal nerve block
was performed after induction of anaesthesia, using
0.5% bupivacaine with 1/200000 adrenaline 30 ml.
All patients had an intercostal incision for thora-
cotomy. At the end of surgery, neuromuscular
block was antagonized, the tracheal tube removed
and the patient transferred to the high dependency
unit.
The study began at the end of surgery and lasted
for 2 days, with one nurse-observer organizing all
the assessments. Subjects had access to i.v. PCA
morphine (Abbott Lifecare PCA plus); bolus 2 mg
and lock out time 15 min.
Patients were given i.m. ketorolac 30 mg, ketorolac
10 mg or placebo 6 hourly in a double-blind fashion
by allocation of a study number (1-75) correspond-
ing to a box of medication containing nine unlabelled
ampoules of ketorolac 30 mg or 10 mg, or placebo.
The first dose of study drug was given at the end of
surgery, before anaesthesia was discontinued and the
others were given 6 hourly. The study ended 2 h
after the last dose, 50 h after the end of surgery.
Patients were withdrawn if they were not given nine
doses of study medication, and the reason noted.
Patients were withdrawn also (and intercostal block
repeated) if they had more than mild pain at rest
which did not respond to PCA morphine in 1 h.
PCA morphine consumption was recorded hourly,
and visual analogue pain scores (VAS) at rest and
after taking a deep breath were performed by the
patient 2 h after the first, fifth and ninth i.m.
injections (days 1, 2 and 3).
The variable used to determine the size of this
study was the use of PCA morphine by the subjects.
We predicted that morphine consumption in the first
24 h would be 60 mg with an SD of 20 mg. A 33 %
difference in morphine usage between groups would
be clinically significant and had been found in
similar studies using ketorolac after abdominal
surgery [2] and with indomethacin after thoracotomy
[3]. Such a difference could be detected with a
statistical power of 75%, at the 5% significance
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TABLE I. Patient details (mean (range or SD)); study completion rates, reasons for withdrawal and the number who withdrew
because of inadequate analgesia (No.); PCA morphine consumption in the subjects remaining in the three study groups at
24 and 48 h, and VAS pain assessments made by the patients on the three study days; morphine and VAS (mean (SEj).











































































































level, with 25 patients in the three treatment groups
[4].
The chi-square test was used to analyse rates of
withdrawal as a result of inadequate analgesia in the
three study groups. One-way analysis of variance
was used to analyse morphine consumption and VAS
results for the patients remaining in the study.
More patients were withdrawn from the placebo
group because of inadequate analgesia than from
either the ketorolac 10 mg (P < 0.05, chi-square) or
the ketorolac 30 mg group (P < 0.01). There was no
difference between the ketorolac groups. The success
rate of the balanced analgesic regimens which
included ketorolac was therefore significantly
greater.
There was no statistically significant difference
between the ketorolac groups in morphine con-
sumption at any time. At 48 h, the placebo group had
used an average of 15 mg more morphine than the
ketorolac 10 mg group (95 % CI - 1 4 to 43 mg, P =
0.18) and the ketorolac 30 mg group (95 % CI - 1 2
to 42 mg, P = 0.32). VAS pain scores in the three
groups were not significantly different.
One patient in the placebo group required ligation
of a bleeding bronchial artery. In the ketorolac
10 mg group, one patient had postoperative myo-
cardial infarction, one mild dyspepsia and one
required suction bronchoscopy to remove retained
secretions. One patient in the ketorolac 30 mg group
had a postoperative bleed after a difficult operation
with many adhesions; coagulation studies and the
skin bleeding time were normal and no treatment
other than transfusion of 2 u. blood was required.
COMMENT
In this study, the addition of ketorolac improved
analgesia after thoracotomy significantly as inter-
costal local anaesthesia and PCA morphine were less
acceptable to patients than when the i.m. non-
steroidal anti-inflammatory drug (NSAID) was
added. This may be further evidence in support of
the use of balanced analgesia, using combinations of
opioids, local anaesthetics and NSAID [5]. As the
design of this study required that patients were
withdrawn if they had more than mild pain at rest, it
was difficult to show any differences in PCA
morphine use or pain scores, because so many
withdrew from the control group.
There was little evidence that ketorolac 30 mg was
better than 10 mg and this may indicate that
ketorolac had a ceiling analgesic effect in this clinical
situation. The dose recommendations for ketorolac
have been reduced recently, and this study would
support the use of the smaller dose of 10 mg when
used as a component of balanced analgesia. There
were no serious adverse effects and, despite the
known effects of NSAID on the kidneys [6], no acute
renal problems were encountered. We conclude that
addition of ketorolac improved the success rate of
analgesia after thoracotomy when intercostal nerve
blocks and PCA morphine were used.
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